ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Responds To IOM Report On Women’s Health Initiative

November 12, 1993

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

NCI Launches ALCHEMIST

September 5, 2014

Cancer Centers Program To Implement Most Changes Sought By review Group

December 13, 1996

Brief: President Expected To Propose 4.7% Increase In NIH Budget; Bernard Fisher Wins Award

January 14, 1994

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002